Daria Zamolodchikov

Title: Daria Zamolodchikov: Innovator in Coagulation Factor Research

Introduction

Daria Zamolodchikov is a prominent inventor based in Hastings-on-Hudson, NY (US). She has made significant contributions to the field of biomedical research, particularly in the area of coagulation factors. With a total of 2 patents, her work is paving the way for advancements in medical science.

Latest Patents

Daria's latest patents focus on non-human animals comprising a humanized coagulation factor XII (F12) locus. These patents detail methods for creating and utilizing non-human animal genomes and cells that express human coagulation factor XII proteins. The innovations include methods for assessing the in vivo efficacy of human-coagulation-factor-XII-targeting reagents, such as nuclease agents designed to target human F12. Additionally, her work explores a short isoform of F12 produced locally in the brain, along with methods for using this short isoform.

Career Highlights

Daria Zamolodchikov is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research in coagulation factors. Her work is instrumental in developing new therapeutic approaches that could significantly impact patient care.

Collaborations

Daria collaborates with notable colleagues, including Yajun Tang and Dan Chalothorn, who contribute to her research endeavors. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Daria Zamolodchikov's contributions to the field of coagulation factor research exemplify the impact of innovative thinking in biomedical science. Her patents and ongoing work at Regeneron Pharmaceuticals, Inc. highlight her role as a leading inventor in this critical area of study.